{"id":191698,"date":"2022-07-21T00:00:00","date_gmt":"2022-07-21T00:00:00","guid":{"rendered":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/"},"modified":"2022-07-25T06:34:52","modified_gmt":"2022-07-25T06:34:52","slug":"carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting","status":"publish","type":"post","link":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/","title":{"rendered":"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue"},"content":{"rendered":"

Carl Zeiss Meditec, one of the world\u2019s leading medical<\/a> technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a part<\/a>nership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.<\/p>\n

<\/p>\n

Under the terms of the agreement, Carl Zeiss Meditec will invest in Precise Bio and fund the further development of Precise Bio\u2019s two cornea transplant products and has exclusive worldwide commercialization rights for these products. Financial terms were not disclosed.<\/p>\n

\u201cThis investment in Precise Bio is expected to complement our leading portfolio of cataract and corneal refractive workflow solutions,\u201d said Euan S. Thomson, Ph.D., President of Ophthalmic Devices and Head of the Digital Business Unit for Carl Zeiss Meditec. \u201cThe technology has the potential to advance treatment options for corneal disease, as well as for elective procedures \u2013 furthering enabling optimization of patient care.\u201d<\/p>\n

\"\"
Precise Bio\u2019s bio-fabricated cornea<\/figcaption><\/figure>\n
\n
\n

Manufacturing on Demand<\/h4>\n
Fast turnaround, low cost, comprehensive optimized strategy\u2026 FacFox is your one-stop partner for product manufacturing!<\/div>\n<\/div>\n

<\/i> Get Quote<\/a><\/p>\n<\/div>\n

\u201cWe are very excited with this part<\/a>nership that builds on our successful, ongoing collaboration with ZEISS for the development of corneal tissues to address unmet needs in the field of ophthalmology,\u201d said Aryeh Batt, Co-founder, and CEO of Precise Bio. \u201cThis strategic agreement leverages ZEISS\u2019 global leadership in ophthalmology and Precise\u2019s innovative and unique 4D bio-fabrication platform technology. We are confident that the synergy between the two companies will allow us to develop breakthrough solutions for recovering patients\u2019 eyesight, bringing hope to hundreds of millions of patients worldwide.\u201d<\/p>\n

Precise Bio combines engineering, biomaterials, cell technology, bioengineering, and 3D printing<\/a> into a 4D bio-fabrication platform for transplantable organs and tissues. The company\u2019s proprietary platform technology allows to fabricate tissues by \u2018printing\u2019 cells in a single-cell resolution and spatial accuracy, enabling complex organoid constructs with both structural integrity and long-term cell viability. Overcoming multiple technology challenges, Precise Bio\u2019s 4D bio-fabrication technology allows to reliably scale up tissue engineering for clinical use, and produce large quantities in a reproducible, quality-controlled, and cost-effective process. Precise Bio\u2019s ophthalmological pipeline consists of three products \u2013 the two cornea products that are the subject of the collaboration with Carl Zeiss Meditec and a retinal implant for age-related macular degeneration, all of which demonstrated successful results in animal models.<\/p>\n

Bio-fabricated tissues comprised of human cells and natural materials, mimicking the anatomical structure and natural tissue components, can replace damaged or diseased tissue, substitute for donor tissue in cases where there is a lack of tissue, or solve unmet therapeutic needs.<\/p>\n

<\/div>\n
<\/div>\n

 <\/p>\n

* This article is reprinted from 3D Printing Media Network<\/a>. If you are involved in infringement, please contact us to delete it.<\/p>\n

<\/i> Author:\u00a0Edward Wakefield<\/p>\n","protected":false},"excerpt":{"rendered":"

Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.<\/p>\n","protected":false},"author":3,"featured_media":191751,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"fifu_image_url":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","fifu_image_alt":"Carl Zeiss Meditec and Precise Bio to develop fabricated corneal tissue Bioprinting","footnotes":""},"categories":[195],"tags":[211,3921,292,129],"class_list":["post-191698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","tag-4d-printing","tag-biofabrication","tag-bioprinting","tag-medical"],"yoast_head":"\nCarl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue - FacFox News<\/title>\n<meta name=\"description\" content=\"Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction. Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue\" \/>\n<meta property=\"og:description\" content=\"Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction. Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/\" \/>\n<meta property=\"og:site_name\" content=\"FacFox News\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-25T06:34:52+00:00\" \/>\n<meta property=\"og:image\" content=\"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg\" \/>\n<meta name=\"author\" content=\"Vera\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Vera\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/\"},\"author\":{\"name\":\"Vera\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/person\/7b701aad2d8f434034fcecd2c50a570c\"},\"headline\":\"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue\",\"datePublished\":\"2022-07-21T00:00:00+00:00\",\"dateModified\":\"2022-07-25T06:34:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/\"},\"wordCount\":484,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/facfox.com\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage\"},\"thumbnailUrl\":\"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg\",\"keywords\":[\"4D printing\",\"Biofabrication\",\"bioprinting\",\"medical\"],\"articleSection\":[\"Medical\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/\",\"url\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/\",\"name\":\"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue - FacFox News\",\"isPartOf\":{\"@id\":\"https:\/\/facfox.com\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage\"},\"thumbnailUrl\":\"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg\",\"datePublished\":\"2022-07-21T00:00:00+00:00\",\"dateModified\":\"2022-07-25T06:34:52+00:00\",\"description\":\"Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction. Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.\",\"breadcrumb\":{\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage\",\"url\":\"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg\",\"contentUrl\":\"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg\",\"caption\":\"Carl Zeiss Meditec and Precise Bio to develop fabricated corneal tissue Bioprinting\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/facfox.com\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/facfox.com\/news\/#website\",\"url\":\"https:\/\/facfox.com\/news\/\",\"name\":\"FacFox News\",\"description\":\"News and Insights of 3D Printing and Manufacturing\",\"publisher\":{\"@id\":\"https:\/\/facfox.com\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/facfox.com\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/facfox.com\/news\/#organization\",\"name\":\"FacFox News\",\"url\":\"https:\/\/facfox.com\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png\",\"contentUrl\":\"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png\",\"width\":200,\"height\":55,\"caption\":\"FacFox News\"},\"image\":{\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/facfox.com\/news\/#\/schema\/person\/7b701aad2d8f434034fcecd2c50a570c\",\"name\":\"Vera\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/bf3b1e47e1f0ed2367da10e343584d5a4adb2e9675fce2aefb04f0ecf3954386?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bf3b1e47e1f0ed2367da10e343584d5a4adb2e9675fce2aefb04f0ecf3954386?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bf3b1e47e1f0ed2367da10e343584d5a4adb2e9675fce2aefb04f0ecf3954386?s=96&d=mm&r=g\",\"caption\":\"Vera\"},\"url\":\"https:\/\/facfox.com\/news\/author\/vera\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue - FacFox News","description":"Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction. Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/","og_locale":"en_US","og_type":"article","og_title":"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue","og_description":"Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction. Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.","og_url":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/","og_site_name":"FacFox News","article_published_time":"2022-07-21T00:00:00+00:00","article_modified_time":"2022-07-25T06:34:52+00:00","og_image":[{"url":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","type":"","width":"","height":""}],"author":"Vera","twitter_card":"summary_large_image","twitter_image":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","twitter_misc":{"Written by":"Vera","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#article","isPartOf":{"@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/"},"author":{"name":"Vera","@id":"https:\/\/facfox.com\/news\/#\/schema\/person\/7b701aad2d8f434034fcecd2c50a570c"},"headline":"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue","datePublished":"2022-07-21T00:00:00+00:00","dateModified":"2022-07-25T06:34:52+00:00","mainEntityOfPage":{"@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/"},"wordCount":484,"commentCount":0,"publisher":{"@id":"https:\/\/facfox.com\/news\/#organization"},"image":{"@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage"},"thumbnailUrl":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","keywords":["4D printing","Biofabrication","bioprinting","medical"],"articleSection":["Medical"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/","url":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/","name":"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue - FacFox News","isPartOf":{"@id":"https:\/\/facfox.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage"},"image":{"@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage"},"thumbnailUrl":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","datePublished":"2022-07-21T00:00:00+00:00","dateModified":"2022-07-25T06:34:52+00:00","description":"Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction. Carl Zeiss Meditec, one of the world\u2019s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.","breadcrumb":{"@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#primaryimage","url":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","contentUrl":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","caption":"Carl Zeiss Meditec and Precise Bio to develop fabricated corneal tissue Bioprinting"},{"@type":"BreadcrumbList","@id":"https:\/\/facfox.com\/news\/carl-zeiss-meditec-and-precise-bio-to-develop-fabricated-corneal-tissue-bioprinting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/facfox.com\/news\/"},{"@type":"ListItem","position":2,"name":"Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue"}]},{"@type":"WebSite","@id":"https:\/\/facfox.com\/news\/#website","url":"https:\/\/facfox.com\/news\/","name":"FacFox News","description":"News and Insights of 3D Printing and Manufacturing","publisher":{"@id":"https:\/\/facfox.com\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/facfox.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/facfox.com\/news\/#organization","name":"FacFox News","url":"https:\/\/facfox.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/","url":"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png","contentUrl":"https:\/\/facfox.com\/news\/wp-content\/uploads\/2020\/11\/facfox-news-homepg-logo-200px.png","width":200,"height":55,"caption":"FacFox News"},"image":{"@id":"https:\/\/facfox.com\/news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/facfox.com\/news\/#\/schema\/person\/7b701aad2d8f434034fcecd2c50a570c","name":"Vera","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/bf3b1e47e1f0ed2367da10e343584d5a4adb2e9675fce2aefb04f0ecf3954386?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bf3b1e47e1f0ed2367da10e343584d5a4adb2e9675fce2aefb04f0ecf3954386?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bf3b1e47e1f0ed2367da10e343584d5a4adb2e9675fce2aefb04f0ecf3954386?s=96&d=mm&r=g","caption":"Vera"},"url":"https:\/\/facfox.com\/news\/author\/vera\/"}]}},"fifu_image_url":"\/wp-content\/uploads\/2022\/07\/8115078294201728318.jpeg","fifu_image_alt":"Carl Zeiss Meditec and Precise Bio to develop fabricated corneal tissue Bioprinting","_links":{"self":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts\/191698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/comments?post=191698"}],"version-history":[{"count":2,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts\/191698\/revisions"}],"predecessor-version":[{"id":191750,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/posts\/191698\/revisions\/191750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/media\/191751"}],"wp:attachment":[{"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/media?parent=191698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/categories?post=191698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/facfox.com\/news\/wp-json\/wp\/v2\/tags?post=191698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}